XML 48 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Parties Transactions (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
May 26, 2017
Jan. 26, 2017
Sep. 30, 2015
Sep. 30, 2017
Sep. 30, 2016
Dec. 29, 2015
Related Parties Transactions (Textual)            
Amount received from BriVision       $ 4,113,000 $ 6,500,000  
Outstanding loan       950,000    
Accrued interest       8,460    
Interest expenses       74,960 10,170  
Common stock new issues     $ 51,958 5,850,000 3,250,000  
Stock based compensation expenses       138,038 397,960  
Consulting service       70,000    
Additional paid-in capital       13,788,574 4,733,461  
Lease rent       5,000    
Rent expenses       $ 52,205 0  
Related party transactions, description      

Pursuant to the Investment and Equity Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by Asiangene at $1.60 per share in a total amount of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December 15, 2017. Asiangene also agreed to loan the proceeds to the Company for working capital purpose. The non-secured loan bears 0% interest rate and is due on demand. As of September 30, 2017, the outstanding loan balance is $160,000.

   
Co-Dev Agreement [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       $ 450,000    
Common stock new issues $ 2,550,000     3,000,000    
Loan Agreement [Member]            
Related Parties Transactions (Textual)            
Total commitment   $ 950,000        
Loan agreement, description  

The loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender.

       
KimhoAgreementtMember            
Related Parties Transactions (Textual)            
Stock based compensation expenses       80,000    
EuroAsiaAgreementMember            
Related Parties Transactions (Textual)            
Stock based compensation expenses       55,000    
Yuangene Corporation [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       3,000  
Aggregate working capital       $ 3,000    
Interest rate percentage       0.00%    
Outstanding advance       $ 3,000    
Additional paid-in capital       70,000    
BioLite Collaborative Agreement [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       0 6,500,000 $ 100,000,000
BioLite Inc [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       6,500,000  
BioFirst Corporation [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       3,950,000  
Asiangene Corporation [Member]            
Related Parties Transactions (Textual)            
Amount received from BriVision       160,000  
BioFirst Collaborative Agreement Agreement [Member]            
Related Parties Transactions (Textual)            
Due to BioFirst       $ 3,000,000